Therapeutic Effect of Chronic Simple Rhinitis by Halotherapy
DOI:
https://doi.org/10.46966/msjar.v7i3.418Abstract
Background: It was first officially recognized as a therapy in 1843 by Polish physician Dr. Feliks Boczkowski, who noticed that the salt mine workers rarely suffered from respiratory issues. It is said that habitual halotherapy was of benefit to therapy of several disease including allergy, asthma, bronchitis, cold, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, chronic rhinitis, paranasal sinusitis, cough, snore and sleep apnea syndrome, stress, fatigue and vasomotor rhinitis. Halotherapy recently was used for almost respiratory disease and has got good effect of allergy, ENT and skin disease for a long time. Halotherapy as a main/assistant therapy has good effect of ENT diseases, which is anti-inflammatory and decrease of edema on mucous membrane of nose, larynx and Paranasal sinusitis and immune-response modulating effect. Purpose: To find the clinical effect of chronic simple rhinitis by halotherapy Object and method: 90 patients with chronic simple rhinitis were included in this study.(male 48, female 42) Conclusion: Clinical effect of chronic simple rhinitis by halotherapy was 84.4%.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Su Hyang Choe , Yun Sun An, Chang Hyon Choe, Un Sim Kang
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
